Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Wamhoff

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal of Medicinal Chemistry|April 13, 2021
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic AcidemiaAllison J Armstrong, Brad R Henke, Maria Sol Collado, et al.
JHEP Reports : Innovation in Hepatology|January 25, 2021
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesisEmma L Shepherd, Raquel Saborano, Ellie Northall, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal of Medicinal Chemistry|April 13, 2021
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic AcidemiaAllison J Armstrong, Brad R Henke, Maria Sol Collado, et al.
JHEP Reports : Innovation in Hepatology|January 25, 2021
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesisEmma L Shepherd, Raquel Saborano, Ellie Northall, et al.
Pageof 7